PATENT CLAIM ANALYSIS

Application Number: 15781303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210160"]

Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Claim (Index 10):
An assay for detecting HTT (Huntingtin protein) using capture/detection antibody pairs, wherein: (i) when HTT is total HTT, the capture/detection antibody pairs are selected from MAB2166/MAB2174 and MAB2166/#5656S; and, (ii) when HTT is mutant HTT, the capture/detection antibody pairs are selected from MAB1574/#5656S, P1874/#5656S and MW1/#5656S.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14160180', '14242282', '13812366', '13653192', '14363051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747121439511421
- 35 USC 102 Novelty (BERT): 0.534777248184196
- Combined Prediction Score: 0.7507186543744475
- Mean Citation Score: 296.341898
- Max Citation Score: 358.8583
- Similarity Product: 203.1821535545588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test